PharmaShots | Incisive News in 3 Shots

Subscribe Now

atamyo therapeutics

Atamyo Therapeutics Reports the US FDA’s IND Clearance of ATA-200 for Treating Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R5)

Atamyo Therapeutics Reports the US FDA’s IND Clearance of ATA-200 for Treating Limb-Girdle Muscular Dystrophy Type 2C/R5 (LGMD2C/R...

November 12, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us